U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Dermal translucency

MedGen UID:
373141
Concept ID:
C1836646
Finding
Synonyms: Translucent skin; Translucent skins
 
HPO: HP:0010648

Definition

An abnormally increased ability of the skin to permit light to pass through (translucency) such that subcutaneous structures such as veins display an increased degree of visibility. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVDermal translucency

Conditions with this feature

Ehlers-Danlos syndrome, type 4
MedGen UID:
82790
Concept ID:
C0268338
Disease or Syndrome
Vascular Ehlers-Danlos syndrome (vEDS) is characterized by arterial, intestinal, and/or uterine fragility; thin, translucent skin; easy bruising; characteristic facial appearance (thin vermilion of the lips, micrognathia, narrow nose, prominent eyes); and an aged appearance to the extremities, particularly the hands. Vascular dissection or rupture, gastrointestinal perforation, or organ rupture are the presenting signs in most adults with vEDS. Arterial rupture may be preceded by aneurysm, arteriovenous fistulae, or dissection but also may occur spontaneously. The majority (60%) of individuals with vEDS who are diagnosed before age 18 years are identified because of a positive family history. Neonates may present with clubfoot, hip dislocation, limb deficiency, and/or amniotic bands. Approximately half of children tested for vEDS in the absence of a positive family history present with a major complication at an average age of 11 years. Four minor diagnostic features – distal joint hypermobility, easy bruising, thin skin, and clubfeet – are most often present in those children ascertained without a major complication.
Barber-Say syndrome
MedGen UID:
230818
Concept ID:
C1319466
Disease or Syndrome
Barber-Say syndrome (BBRSAY) is a rare congenital condition characterized by severe hypertrichosis, especially of the back, skin abnormalities such as hyperlaxity and redundancy, and facial dysmorphism, including macrostomia, eyelid deformities, ocular telecanthus, abnormal and low-set ears, bulbous nasal tip with hypoplastic alae nasi, and low frontal hairline (summary by Roche et al., 2010).
Loeys-Dietz syndrome 2
MedGen UID:
382398
Concept ID:
C2674574
Disease or Syndrome
Loeys-Dietz syndrome (LDS) is characterized by vascular findings (cerebral, thoracic, and abdominal arterial aneurysms and/or dissections), skeletal manifestations (pectus excavatum or pectus carinatum, scoliosis, joint laxity, arachnodactyly, talipes equinovarus, cervical spine malformation and/or instability), craniofacial features (widely spaced eyes, strabismus, bifid uvula / cleft palate, and craniosynostosis that can involve any sutures), and cutaneous findings (velvety and translucent skin, easy bruising, and dystrophic scars). Individuals with LDS are predisposed to widespread and aggressive arterial aneurysms and pregnancy-related complications including uterine rupture and death. Individuals with LDS can show a strong predisposition for allergic/inflammatory disease including asthma, eczema, and reactions to food or environmental allergens. There is also an increased incidence of gastrointestinal inflammation including eosinophilic esophagitis and gastritis or inflammatory bowel disease. Wide variation in the distribution and severity of clinical features can be seen in individuals with LDS, even among affected individuals within a family who have the same pathogenic variant.
Fontaine progeroid syndrome
MedGen UID:
394125
Concept ID:
C2676780
Disease or Syndrome
SLC25A24 Fontaine progeroid syndrome is a multisystem connective tissue disorder characterized by poor growth, abnormal skeletal features, and distinctive craniofacial features with sagging, thin skin, and decreased subcutaneous fat suggesting an aged appearance that is most pronounced in infancy and improves with time. Characteristic radiographic features include turribrachycephaly with widely open anterior fontanelle, craniosynostosis, and anomalies of the terminal phalanges. Cardiovascular, genitourinary, ocular, and gastrointestinal abnormalities may also occur. To date, 13 individuals with a molecularly confirmed diagnosis of SLC25A24 Fontaine progeroid syndrome have been described.
Ehlers-Danlos syndrome, dermatosparaxis type
MedGen UID:
397792
Concept ID:
C2700425
Disease or Syndrome
Dermatosparaxis (meaning 'tearing of skin') is an autosomal recessive disorder of connective tissue resulting from deficiency of procollagen peptidase, an enzyme that aids in the processing of type I procollagen. The disorder and the responsible biochemical defect was first observed in cattle (Lapiere et al., 1971). Lapiere and Nusgens (1993) reviewed the discovery of dermatosparaxis in cattle, the elucidation of the disorder, its occurrence in other animals, and the delayed recognition of the disorder in the human.
Aneurysm-osteoarthritis syndrome
MedGen UID:
462437
Concept ID:
C3151087
Disease or Syndrome
Loeys-Dietz syndrome (LDS) is characterized by vascular findings (cerebral, thoracic, and abdominal arterial aneurysms and/or dissections), skeletal manifestations (pectus excavatum or pectus carinatum, scoliosis, joint laxity, arachnodactyly, talipes equinovarus, cervical spine malformation and/or instability), craniofacial features (widely spaced eyes, strabismus, bifid uvula / cleft palate, and craniosynostosis that can involve any sutures), and cutaneous findings (velvety and translucent skin, easy bruising, and dystrophic scars). Individuals with LDS are predisposed to widespread and aggressive arterial aneurysms and pregnancy-related complications including uterine rupture and death. Individuals with LDS can show a strong predisposition for allergic/inflammatory disease including asthma, eczema, and reactions to food or environmental allergens. There is also an increased incidence of gastrointestinal inflammation including eosinophilic esophagitis and gastritis or inflammatory bowel disease. Wide variation in the distribution and severity of clinical features can be seen in individuals with LDS, even among affected individuals within a family who have the same pathogenic variant.
Cutis laxa, autosomal recessive, type 1B
MedGen UID:
482428
Concept ID:
C3280798
Disease or Syndrome
EFEMP2-related cutis laxa, or autosomal recessive cutis laxa type 1B (ARCL1B), is characterized by cutis laxa and systemic involvement, most commonly arterial tortuosity, aneurysms, and stenosis; retrognathia; joint laxity; and arachnodactyly. Severity ranges from perinatal lethality as a result of cardiopulmonary failure to manifestations limited to the vascular and craniofacial systems.
PYCR1-related de Barsy syndrome
MedGen UID:
482429
Concept ID:
C3280799
Disease or Syndrome
De Barsy syndrome, also known as autosomal recessive cutis laxa type III (ARCL3), is a rare autosomal recessive disorder characterized by an aged appearance with distinctive facial features, sparse hair, ophthalmologic abnormalities, intrauterine growth retardation (IUGR), and cutis laxa (summary by Lin et al., 2011). For a phenotypic description and a discussion of genetic heterogeneity of de Barsy syndrome, see 219150. For a phenotypic description and a discussion of genetic heterogeneity of autosomal recessive cutis laxa, see 219200.
Ehlers-Danlos syndrome, spondylodysplastic type, 2
MedGen UID:
815540
Concept ID:
C3809210
Disease or Syndrome
The features of Ehlers-Danlos syndrome spondylodysplastic type 2 (EDSSPD2) include an aged appearance, developmental delay, short stature, craniofacial disproportion, generalized osteopenia, defective wound healing, hypermobile joints, hypotonic muscles, and loose but elastic skin (Okajima et al., 1999). For a discussion of genetic heterogeneity of the spondylodysplastic type of Ehlers-Danlos syndrome, see 130070.
Cutis laxa, autosomal dominant 3
MedGen UID:
899774
Concept ID:
C4225268
Disease or Syndrome
Autosomal dominant cutis laxa-3 is characterized by thin skin with visible veins and wrinkles, cataract or corneal clouding, clenched fingers, pre- and postnatal growth retardation, and moderate intellectual disability. In addition, patients exhibit a combination of muscular hypotonia with brisk muscle reflexes (Fischer-Zirnsak et al., 2015). For a general phenotypic description and discussion of genetic heterogeneity of autosomal dominant cutis laxa, see ARCL1 (123700).
Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome
MedGen UID:
1373459
Concept ID:
C4317151
Disease or Syndrome
Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome is an autosomal dominant disorder characterized by these 4 features, which begin in early childhood and are progressive (summary by Moalem et al., 2015).
Noonan syndrome-like disorder with loose anagen hair 2
MedGen UID:
1376945
Concept ID:
C4479577
Disease or Syndrome
An inherited condition caused by autosomal dominant mutation(s) in the PPP1CB gene, encoding serine/threonine-protein phosphatase PP1-beta catalytic subunit. The condition is characterized by facial features similar to those seen in Noonan syndrome but may also include short stature, cognitive deficits, relative macrocephaly, small posterior fossa resulting in Chiari I malformation, hypernasal voice, cardiac defects, and ectodermal abnormalities, which typically presents as slow-growing, sparse, and/or unruly hair.
Pilarowski-Bjornsson syndrome
MedGen UID:
1619150
Concept ID:
C4540131
Disease or Syndrome
Pilarowski-Bjornsson syndrome (PILBOS) is an autosomal dominant neurodevelopmental disorder characterized by delayed development, impaired intellectual development, often with autistic features, speech apraxia, and mild dysmorphic features. Some patients may have seizures. The phenotype is somewhat variable (summary by Pilarowski et al., 2018).
Loeys-Dietz syndrome 1
MedGen UID:
1646567
Concept ID:
C4551955
Disease or Syndrome
Loeys-Dietz syndrome (LDS) is characterized by vascular findings (cerebral, thoracic, and abdominal arterial aneurysms and/or dissections), skeletal manifestations (pectus excavatum or pectus carinatum, scoliosis, joint laxity, arachnodactyly, talipes equinovarus, cervical spine malformation and/or instability), craniofacial features (widely spaced eyes, strabismus, bifid uvula / cleft palate, and craniosynostosis that can involve any sutures), and cutaneous findings (velvety and translucent skin, easy bruising, and dystrophic scars). Individuals with LDS are predisposed to widespread and aggressive arterial aneurysms and pregnancy-related complications including uterine rupture and death. Individuals with LDS can show a strong predisposition for allergic/inflammatory disease including asthma, eczema, and reactions to food or environmental allergens. There is also an increased incidence of gastrointestinal inflammation including eosinophilic esophagitis and gastritis or inflammatory bowel disease. Wide variation in the distribution and severity of clinical features can be seen in individuals with LDS, even among affected individuals within a family who have the same pathogenic variant.
Cerebroretinal microangiopathy with calcifications and cysts 1
MedGen UID:
1636142
Concept ID:
C4552029
Disease or Syndrome
Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.
Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome
MedGen UID:
1675672
Concept ID:
C5193040
Disease or Syndrome
Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome is an autosomal recessive disorder with a highly variable phenotype. Although all patients have polymicrogyria and other variable structural brain anomalies on imaging, only some show developmental delay and/or seizures. Similarly, only some patients have connective tissue defects that particularly affect the vascular system and can result in early death (summary by Vandervore et al., 2017).
Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1
MedGen UID:
1763836
Concept ID:
C5436842
Disease or Syndrome
Combined osteogenesis imperfecta and Ehlers-Danlos syndrome-1 (OIEDS1) is an autosomal dominant generalized connective tissue disorder characterized by features of both osteogenesis imperfecta (bone fragility, long bone fractures, blue sclerae) and Ehlers-Danlos syndrome (joint hyperextensibility, soft and hyperextensible skin, abnormal wound healing, easy bruising, vascular fragility) (summary by Cabral et al., 2007; Malfait et al., 2013). Genetic Heterogeneity of Combined Osteogenesis Imperfecta and Ehlers-Danlos Syndrome Also see OIEDS2 (619120), caused by mutation in the COL1A2 gene (120160) on chromosome 7q21.
Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2
MedGen UID:
1751229
Concept ID:
C5436847
Disease or Syndrome
Combined osteogenesis imperfecta and Ehlers-Danlos syndrome-2 (OIEDS2) is an autosomal dominant generalized connective tissue disorder characterized by features of both osteogenesis imperfecta (bone fragility, long bone fractures, blue sclerae) and Ehlers-Danlos syndrome (joint hyperextensibility, soft and hyperextensible skin, abnormal wound healing, easy bruising, vascular fragility) (summary by Raff et al., 2000 and Malfait et al., 2013). For a discussion of genetic heterogeneity of combined osteogenesis imperfecta and Ehlers-Danlos syndrome, see 619115.
Fibromuscular dysplasia, multifocal
MedGen UID:
1778238
Concept ID:
C5543412
Disease or Syndrome
Multifocal fibromuscular dysplasia (FMDMF) is characterized histologically by medial fibroplasia and angiographically by multiple arterial stenoses with intervening mural dilations. Arterial tortuosity, macroaneurysms, dissections, and rupture may occur (summary by Richer et al., 2020).
Liver disease, severe congenital
MedGen UID:
1823968
Concept ID:
C5774195
Disease or Syndrome
Severe congenital liver disease (SCOLIV) is an autosomal recessive disorder characterized by the onset of progressive hepatic dysfunction usually in the first years of life. Affected individuals show feeding difficulties with failure to thrive and features such as jaundice, hepatomegaly, and abdominal distension. Laboratory workup is consistent with hepatic insufficiency and may also show coagulation defects, anemia, or metabolic disturbances. Cirrhosis and hypernodularity are commonly observed on liver biopsy. Many patients die of liver failure in early childhood (Moreno Traspas et al., 2022).

Professional guidelines

PubMed

Carvalheiro M, Vieira J, Faria-Silva C, Marto J, Simões S
Drug Deliv Transl Res 2021 Apr;11(2):717-728. Epub 2021 Feb 3 doi: 10.1007/s13346-021-00910-z. PMID: 33534106
Wallace RG, Kenealy MR, Brady AJ, Twomey L, Duffy E, Degryse B, Caballero-Lima D, Moyna NM, Custaud MA, Meade-Murphy G, Morrin A, Murphy RP
Burns 2020 Nov;46(7):1585-1602. Epub 2020 May 14 doi: 10.1016/j.burns.2020.04.036. PMID: 32475797

Recent clinical studies

Etiology

Maarof M, Mh Busra MF, Lokanathan Y, Bt Hj Idrus R, Rajab NF, Chowdhury SR
Drug Deliv Transl Res 2019 Feb;9(1):144-161. doi: 10.1007/s13346-018-00612-z. PMID: 30547385
Ferreli C, Caravano M, Fumo G, Rongioletti F
G Ital Dermatol Venereol 2018 Dec;153(6):847-854. Epub 2018 Jul 18 doi: 10.23736/S0392-0488.18.06101-1. PMID: 30019575
Kim HJ, Baek JH, Eo JE, Choi KM, Shin MK, Koh JS
Skin Res Technol 2015 Feb;21(1):41-6. Epub 2014 Sep 12 doi: 10.1111/srt.12154. PMID: 25216021
Martínez-Lage JF, Almagro MJ, Ferri-Ñiguez B, Izura Azanza V, Serrano C, Domenech E
Childs Nerv Syst 2011 Apr;27(4):609-16. Epub 2010 Oct 27 doi: 10.1007/s00381-010-1308-6. PMID: 20978770
Fujioka M, Gozo N, Osamu M, Tsuneyuki Y, Takehisa Y
Dermatology 2003;207(3):316-8. doi: 10.1159/000073097. PMID: 14571077

Diagnosis

Ferreli C, Caravano M, Fumo G, Rongioletti F
G Ital Dermatol Venereol 2018 Dec;153(6):847-854. Epub 2018 Jul 18 doi: 10.23736/S0392-0488.18.06101-1. PMID: 30019575
May C, Chang O, Compton N
Dermatol Online J 2017 Sep 15;23(9) PMID: 29469730
Azimi SZ, Zargari O, Rudolph RI
J Cosmet Dermatol 2017 Dec;16(4):e45-e47. Epub 2017 Mar 9 doi: 10.1111/jocd.12325. PMID: 28276195
Martínez-Lage JF, Almagro MJ, Ferri-Ñiguez B, Izura Azanza V, Serrano C, Domenech E
Childs Nerv Syst 2011 Apr;27(4):609-16. Epub 2010 Oct 27 doi: 10.1007/s00381-010-1308-6. PMID: 20978770
Wambacher-Gasser B, Zelger B, Zelger BG, Steiner H
Histopathology 1997 Jan;30(1):64-9. doi: 10.1046/j.1365-2559.1997.d01-557.x. PMID: 9023559

Therapy

Claes KEY, De Decker I, Monstrey S, Shoham Y, Vyncke T, Depypere B, De Wolf E, Decuypere F, Lannau B, Hoeksema H
Burns 2023 Feb;49(1):80-90. Epub 2022 Jan 6 doi: 10.1016/j.burns.2022.01.004. PMID: 35177282
Wallace RG, Kenealy MR, Brady AJ, Twomey L, Duffy E, Degryse B, Caballero-Lima D, Moyna NM, Custaud MA, Meade-Murphy G, Morrin A, Murphy RP
Burns 2020 Nov;46(7):1585-1602. Epub 2020 May 14 doi: 10.1016/j.burns.2020.04.036. PMID: 32475797
Maarof M, Mh Busra MF, Lokanathan Y, Bt Hj Idrus R, Rajab NF, Chowdhury SR
Drug Deliv Transl Res 2019 Feb;9(1):144-161. doi: 10.1007/s13346-018-00612-z. PMID: 30547385
Barrick C, Moran J, Oram C, Purcell S
Cutis 2018 Nov;102(5):344-346. PMID: 30566539
Stalling SS, Akintoye SO, Nicoll SB
Acta Biomater 2009 Jul;5(6):1911-8. Epub 2009 Feb 20 doi: 10.1016/j.actbio.2009.02.020. PMID: 19303378

Prognosis

Claes KEY, De Decker I, Monstrey S, Shoham Y, Vyncke T, Depypere B, De Wolf E, Decuypere F, Lannau B, Hoeksema H
Burns 2023 Feb;49(1):80-90. Epub 2022 Jan 6 doi: 10.1016/j.burns.2022.01.004. PMID: 35177282
Ferreli C, Caravano M, Fumo G, Rongioletti F
G Ital Dermatol Venereol 2018 Dec;153(6):847-854. Epub 2018 Jul 18 doi: 10.23736/S0392-0488.18.06101-1. PMID: 30019575
Hatake K, Morimura Y, Kudo R, Kawashima W, Kasuda S, Kuniyasu H
Leg Med (Tokyo) 2013 Jan;15(1):23-7. Epub 2012 Aug 30 doi: 10.1016/j.legalmed.2012.07.005. PMID: 22940417
Fujioka M, Gozo N, Osamu M, Tsuneyuki Y, Takehisa Y
Dermatology 2003;207(3):316-8. doi: 10.1159/000073097. PMID: 14571077
Nijsten TE, De Moor A, Colpaert CG, Robert K, Mahieu LM, Lambert J
Pediatr Dermatol 2002 Jan-Feb;19(1):67-72. doi: 10.1046/j.1525-1470.2002.00029.x. PMID: 11860576

Clinical prediction guides

Claes KEY, De Decker I, Monstrey S, Shoham Y, Vyncke T, Depypere B, De Wolf E, Decuypere F, Lannau B, Hoeksema H
Burns 2023 Feb;49(1):80-90. Epub 2022 Jan 6 doi: 10.1016/j.burns.2022.01.004. PMID: 35177282
Carvalheiro M, Vieira J, Faria-Silva C, Marto J, Simões S
Drug Deliv Transl Res 2021 Apr;11(2):717-728. Epub 2021 Feb 3 doi: 10.1007/s13346-021-00910-z. PMID: 33534106
Saleem U, Khalid S, Zaib S, Anwar F, Ahmad B, Ullah I, Zeb A, Ayaz M
J Ethnopharmacol 2020 Mar 1;249:112401. Epub 2019 Nov 15 doi: 10.1016/j.jep.2019.112401. PMID: 31739103
Ferreli C, Caravano M, Fumo G, Rongioletti F
G Ital Dermatol Venereol 2018 Dec;153(6):847-854. Epub 2018 Jul 18 doi: 10.23736/S0392-0488.18.06101-1. PMID: 30019575
Shimaoka Y, Kosho T, Wataya-Kaneda M, Funakoshi M, Suzuki T, Hayashi S, Mitsuhashi Y, Isei T, Aoki Y, Yamazaki K, Ono M, Makino K, Tanaka T, Kunii E, Hatamochi A
Br J Dermatol 2010 Oct;163(4):704-10. doi: 10.1111/j.1365-2133.2010.09874.x. PMID: 20518783

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...